CLEO Diagnostics LtdASX: COV

Letter to Shareholders

· Issued by CLEO Diagnostics Ltd via ASX

Filed with ASX · · 1 page · English

Release

Cleo Diagnostics Ltd ASX:COV Level 2, 480 Collins Street, Melbourne, VIC, 3000 ACN 655 717 169 T +61 3 9614 0600 E [email protected] Directors Chair and Non-Executive Director Adrien Wing Chief Executive Officer and Executive Director Dr Richard Allman Chief Scientific Officer and Executive...

CLEO Diagnostics Ltd on 6ix

Earlier from CLEO Diagnostics

Later from CLEO Diagnostics

All CLEO Diagnostics news releases